Acadia Healthcare Shares Plummet After Liability Expense Alert
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 03 Dec 25
Source: Benzinga
Acadia Healthcare's stock fell 12.80% after crossing down the 5-day SMA, reflecting investor concerns over rising liability expenses.
The company has revised its 2025 EBITDA guidance down by $49 million, primarily due to increased professional and general liability expenses. This significant rise in costs has raised doubts about future profitability and investor confidence.
With liability expenses projected to reach approximately $116 million in 2025, up from $54 million in 2024, the market reaction indicates a strong negative sentiment towards Acadia's financial outlook.
Analyst Views on ACHC
Wall Street analysts forecast ACHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACHC is 19.55 USD with a low forecast of 13.00 USD and a high forecast of 27.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Analyst Rating
6 Buy
4 Hold
1 Sell
Moderate Buy
Current: 13.440
Low
13.00
Averages
19.55
High
27.00
Current: 13.440
Low
13.00
Averages
19.55
High
27.00
About ACHC
Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services across the United States. It provides behavioral healthcare services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics. Its acute inpatient psychiatric facilities provide a high level of care in order to stabilize patients that are either a threat to themselves or to others. Its specialty treatment facilities include residential recovery facilities and eating disorder facilities. Its comprehensive treatment centers specialize in providing medication-assisted treatment in an outpatient setting. Its residential treatment centers treat patients with behavioral disorders in a non-hospital setting. The facilities balance therapy activities with social, academic and other activities. It operates a network of 262 behavioral healthcare facilities with over 11,850 beds in 39 states and Puerto Rico.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
